Suchergebnisse - "de Azambuja, E"

PubPharm (41)

1

Abstract P4-21-09: Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2 positive early breast cancer (BIG 1-06)

enthalten in: Cancer research | 2017

von de Azambuja, E. | Bradbury, I. | Ewer, M. | +13

2

Abstract P2-09-05: 12 years' median follow up (MFU) of BIG 1-98: Adjuvant letrozole, tamoxifen and their sequence for postmenopausal women with endocrine responsive early breast cancer

enthalten in: Cancer research | 2017

von Thürlimann, B. | Giobbie-Hurder, A. | Colleoni, M. | +16

3

Abstract S3-02: Plasma microRNA levels for predicting therapeutic response to neoadjuvant treatment in HER2-positive breast cancer: Results from Neo-ALTTO

enthalten in: Cancer research | 2017

von Di Cosimo, S. | Appierto, V. | Tiberio, P. | +13

4

The prognostic role of androgen receptor in patients with early stage breast cancer: A meta-analysis of clinical and gene expression data

enthalten in: Clinical cancer research | 2016

von Bozovic-Spasojevic, I. | Zardavas, D. | Brohee, S. | +8

5

The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients: an international multicentre hospital-based retrospective cohort study

enthalten in: Annals of oncology | 2016

von Lambertini, M. | Pinto, A. | Ameye, L. | +12

6

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)

enthalten in: Annals of oncology | 2015

von Gourgou-Bourgade, S. | Cameron, D. | Poortmans, P. | +42

7

Duration of endocrine therapy and its impact on the results of adjuvant trials in premenopausal breast cancer patients

enthalten in: Annals of oncology | 2015

von Fouad, T. | de Azambuja, E. | Azim, J.

8

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)

enthalten in: Annals of oncology | 2015

von Gourgou-Bourgade, S. | Cameron, D. | Poortmans, P. | +42

9

Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): A European survey conducted by the European Society for Medical Oncology (ESMO) Young Oncologists Committee

enthalten in: Lung cancer | 2014

von Califano, R. | Karamouzis, M. | Banerjee, S. | +11

10

Factors affecting surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial

enthalten in: Annals of oncology | 2014

von Criscitiello, C. | Azim, H. | de Azambuja, E. | +1

1
2
3
4
5
Nächster »
[5]